A review of new science, in plain language

Science  ·  3 September 2026  ·  From issue 32

(Un)intended consequences of mass-prescribing GLP-1s

Fair access to popular weight loss drugs faces threats from competing business interests.

Luc L. Hagenaars, Laura A. Schmidt.

The World Health Organization now tells countries to use a class of weight loss drugs to treat obesity. These drugs also get used for skin problems, sexual issues, and addiction. WHO wants fair access for the 1 billion people worldwide who have obesity. But drug makers, food companies, and wellness brands are all racing to cash in, which could make fair access harder to reach.

Integrity screen: passed (3 checks) Checked 10 September 2026. Read the source

The plain-language reading of this paper is in the full issue, for subscribers.

Read the full issue

Five vetted papers in plain language, free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 32 15 papers
More from Science